Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
732,70 €
6,68 %
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $815.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Morgan Stanley from $805.00 to $950.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $815.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Bank of America Co. from $800.00 to $1,000.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $850.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $815.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Citigroup Inc. from $675.00 to $895.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $815.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $885.00 price target on the stock, up previously from $815.00.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Truist Financial Co. from $850.00 to $892.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at JPMorgan Chase & Co. from $850.00 to $900.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
Roth_Mkm in Advanced Micro Devices Inc. diskutieren